1
|
Candido J and Hagemann T: Cancer-related
inflammation. J Clin Immunol. 33 Suppl 1:S79–S84. 2013. View Article : Google Scholar : PubMed/NCBI
|
2
|
Gao D, Vahdat LT, Wong S, Chang JC and
Mittal V: Microenvironmental regulation of epithelial-mesenchymal
transitions in cancer. Cancer Res. 72:4883–4889. 2012. View Article : Google Scholar : PubMed/NCBI
|
3
|
Schwitalla S, Fingerle AA, Cammareri P,
Nebelsiek T, Göktuna SI, Ziegler PK, Canli O, Heijmans J, Huels DJ,
Moreaux G, et al: Intestinal tumorigenesis initiated by
dedifferentiation and acquisition of stem-cell-like properties.
Cell. 152:25–38. 2013. View Article : Google Scholar : PubMed/NCBI
|
4
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: Acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
5
|
Jung HY, Fattet L and Yang J: Molecular
pathways: Linking tumor microenvironment to epithelial-mesenchymal
transition in metastasis. Clin Cancer Res. 21:962–968. 2015.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Hawinkels LJ, Verspaget HW, van der
Reijden JJ, van der Zon JM, Verheijen JH, Hommes DW, Lamers CB and
Sier CF: Active TGF-beta1 correlates with myofibroblasts and
malignancy in the colorectal adenoma-carcinoma sequence. Cancer
Sci. 100:663–670. 2009. View Article : Google Scholar : PubMed/NCBI
|
7
|
Balkwill F: Tumour necrosis factor and
cancer. Nat Rev Cancer. 9:361–371. 2009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Wu Y and Zhou BP:
TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and
invasion. Br J Cancer. 102:639–644. 2010. View Article : Google Scholar : PubMed/NCBI
|
9
|
Borthwick LA, McIlroy EI, Gorowiec MR,
Brodlie M, Johnson GE, Ward C, Lordan JL, Corris PA, Kirby JA and
Fisher AJ: Inflammation and epithelial to mesenchymal transition in
lung transplant recipients: Role in dysregulated epithelial wound
repair. Am J Transplant. 10:498–509. 2010. View Article : Google Scholar : PubMed/NCBI
|
10
|
Bates RC and Mercurio AM: Tumor necrosis
factor-alpha stimulates the epithelial-to-mesenchymal transition of
human colonic organoids. Mol Biol Cell. 14:1790–1800. 2003.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Borthwick LA, Gardner A, De Soyza A, Mann
DA and Fisher AJ: Transforming Growth Factor-β1 (TGF-β1) driven
epithelial to mesenchymal transition (EMT) is accentuated by tumour
necrosis factor α (TNFα) via crosstalk between the SMAD and NF-κB
pathways. Cancer Microenviron. 5:45–57. 2012. View Article : Google Scholar : PubMed/NCBI
|
12
|
Pino MS, Kikuchi H, Zeng M, Herraiz MT,
Sperduti I, Berger D, Park DY, Iafrate AJ, Zukerberg LR and Chung
DC: Epithelial to mesenchymal transition is impaired in colon
cancer cells with microsatellite instability. Gastroenterology.
138:1406–1417. 2010. View Article : Google Scholar : PubMed/NCBI
|
13
|
Kyriakis JM and Avruch J: Protein kinase
cascades activated by stress and inflammatory cytokines. Bioessays.
18:567–577. 1996. View Article : Google Scholar : PubMed/NCBI
|
14
|
Ellenrieder V, Hendler SF, Boeck W,
Seufferlein T, Menke A, Ruhland C, Adler G and Gress TM:
Transforming growth factor beta1 treatment leads to an
epithelial-mesenchymal transdifferentiation of pancreatic cancer
cells requiring extracellular signal-regulated kinase 2 activation.
Cancer Res. 61:4222–4228. 2001.PubMed/NCBI
|
15
|
Zavadil J, Bitzer M, Liang D, Yang YC,
Massimi A, Kneitz S, Piek E and Bottinger EP: Genetic programs of
epithelial cell plasticity directed by transforming growth
factor-beta. Proc Natl Acad Sci USA. 98:6686–6691. 2001. View Article : Google Scholar : PubMed/NCBI
|
16
|
Obata T, Brown GE and Yaffe MB: MAP kinase
pathways activated by stress: The p38 MAPK pathway. Crit Care Med.
28 4 Suppl:N67–N77. 2000. View Article : Google Scholar : PubMed/NCBI
|
17
|
Young PE, Womeldorph CM, Johnson EK,
Maykel JA, Brucher B, Stojadinovic A, Avital I, Nissan A and Steele
SR: Early detection of colorectal cancer recurrence in patients
undergoing surgery with curative intent: Current status and
challenges. J Cancer. 5:262–271. 2014. View
Article : Google Scholar : PubMed/NCBI
|
18
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
19
|
Fuxe J and Karlsson MC: TGF-β-induced
epithelial-mesenchymal transition: A link between cancer and
inflammation. Semin Cancer Biol. 22:455–461. 2012. View Article : Google Scholar : PubMed/NCBI
|
20
|
Brown KA, Aakre ME, Gorska AE, Price JO,
Eltom SE, Pietenpol JA and Moses HL: Induction by transforming
growth factor-beta1 of epithelial to mesenchymal transition is a
rare event in vitro. Breast Cancer Res. 6:R215–R231. 2004.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Thiery JP: Epithelial-mesenchymal
transitions in development and pathologies. Curr Opin Cell Biol.
15:740–746. 2003. View Article : Google Scholar : PubMed/NCBI
|
22
|
Hamadien MA, Khan Z, Vaali-Mohammed MA,
Zubaidi A, Al-Khayal K, McKerrow J and Al-Obeed O: Polymorphisms of
tumor necrosis factor alpha in Middle Eastern population with
colorectal cancer. Tumour Biol. 37:5529–5537. 2016. View Article : Google Scholar : PubMed/NCBI
|
23
|
Al Obeed OA, Alkhayal KA, Al Sheikh A,
Zubaidi AM, Vaali-Mohammed MA, Boushey R, Mckerrow JH and Abdulla
MH: Increased expression of tumor necrosis factor-α is associated
with advanced colorectal cancer stages. World J Gastroenterol.
20:18390–18396. 2014. View Article : Google Scholar : PubMed/NCBI
|
24
|
Buonato JM and Lazzara MJ: ERK1/2 blockade
prevents epithelial-mesenchymal transition in lung cancer cells and
promotes their sensitivity to EGFR inhibition. Cancer Res.
74:309–319. 2014. View Article : Google Scholar : PubMed/NCBI
|
25
|
Chen X, Xiao W, Wang W, Luo L, Ye S and
Liu Y: The complex interplay between ERK1/2, TGFβ/Smad, and
Jagged/Notch signaling pathways in the regulation of
epithelial-mesenchymal transition in retinal pigment epithelium
cells. PLoS One. 9:e963652014. View Article : Google Scholar : PubMed/NCBI
|
26
|
Xie L, Law BK, Chytil AM, Brown KA, Aakre
ME and Moses HL: Activation of the Erk pathway is required for
TGF-beta1-induced EMT in vitro. Neoplasia. 6:603–610. 2004.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Itoigawa Y, Harada N, Harada S, Katsura Y,
Makino F, Ito J, Nurwidya F, Kato M, Takahashi F, Atsuta R and
Takahashi K: TWEAK enhances TGF-β-induced epithelial-mesenchymal
transition in human bronchial epithelial cells. Respir Res.
16:482015. View Article : Google Scholar : PubMed/NCBI
|
28
|
Zhong H, May MJ, Jimi E and Ghosh S: The
phosphorylation status of nuclear NF-kappa B determines its
association with CBP/p300 or HDAC-1. Mol Cell. 9:625–636. 2002.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Xia Y, Shen S and Verma IM: NF-κB, an
active player in human cancers. Cancer Immunol Res. 2:823–830.
2014. View Article : Google Scholar : PubMed/NCBI
|
30
|
Bradford JW and Baldwin AS: IKK/nuclear
factor-kappaB and oncogenesis: Roles in tumor-initiating cells and
in the tumor microenvironment. Adv Cancer Res. 121:125–145. 2014.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Epanchintsev A, Shyamsunder P, Verma RS
and Lyakhovich A: IL-6, IL-8, MMP-2, MMP-9 are overexpressed in
Fanconi anemia cells through a NF-κB/TNF-α dependent mechanism. Mol
Carcinog. 54:1686–1699. 2015. View
Article : Google Scholar : PubMed/NCBI
|
32
|
Chua HL, Bhat-Nakshatri P, Clare SE,
Morimiya A, Badve S and Nakshatri H: NF-kappaB represses E-cadherin
expression and enhances epithelial to mesenchymal transition of
mammary epithelial cells: Potential involvement of ZEB-1 and ZEB-2.
Oncogene. 26:711–724. 2007. View Article : Google Scholar : PubMed/NCBI
|